Royalty Pharma Drops $8B Hostile Bid For Elan
Royalty Pharma Inc. has walked away from a hostile $8 billion bid for Irish drug company Elan Corp. PLC, on Tuesday dropping a legal appeal that might have kept it alive....To view the full article, register now.
Already a subscriber? Click here to view full article